000 01589 a2200433 4500
005 20250515065236.0
264 0 _c20071004
008 200710s 0 0 eng d
022 _a0022-3042
024 7 _a10.1111/j.1471-4159.2007.04613.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarcia-Alloza, M
245 0 0 _aCurcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.
_h[electronic resource]
260 _bJournal of neurochemistry
_cAug 2007
300 _a1095-104 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aAmyloid beta-Peptides
_xmetabolism
650 0 4 _aAmyloid beta-Protein Precursor
_xgenetics
650 0 4 _aAnimals
650 0 4 _aCurcumin
_xmetabolism
650 0 4 _aDisease Models, Animal
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Transgenic
650 0 4 _aNeurites
_xdrug effects
650 0 4 _aNeurons
_xpathology
650 0 4 _aNeuroprotective Agents
_xmetabolism
650 0 4 _aPresenilin-1
_xgenetics
700 1 _aBorrelli, L A
700 1 _aRozkalne, A
700 1 _aHyman, B T
700 1 _aBacskai, B J
773 0 _tJournal of neurochemistry
_gvol. 102
_gno. 4
_gp. 1095-104
856 4 0 _uhttps://doi.org/10.1111/j.1471-4159.2007.04613.x
_zAvailable from publisher's website
999 _c17020599
_d17020599